Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Phathom Pharmaceuticals, Inc. (PHAT) had Earnings per Share (EPS) (Basic) of $-0.41 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$49.50M |
|
$-29.97M |
|
$6.19M |
|
$43.31M |
|
$64.78M |
|
$-15.27M |
|
$-14.70M |
|
$-29.97M |
|
$-29.97M |
|
$-29.97M |
|
$-29.97M |
|
$-29.97M |
|
$-29.97M |
|
$-15.27M |
|
$-14.34M |
|
73.40M |
|
73.40M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.41 |
$-0.41 |
|
| Balance Sheet Financials | |
$207.78M |
|
$1.16M |
|
$32.51M |
|
$240.29M |
|
$93.12M |
|
$207.09M |
|
$569.70M |
|
$662.82M |
|
$-422.53M |
|
$-422.53M |
|
$-422.53M |
|
71.04M |
|
| Cash Flow Statement Financials | |
$-161.77M |
|
$-0.14M |
|
$-0.19M |
|
$300.12M |
|
$138.02M |
|
$-162.11M |
|
$23.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.23 |
|
-- |
|
-- |
|
-0.96 |
|
-0.49 |
|
87.50% |
|
-30.85% |
|
-30.85% |
|
-- |
|
-60.55% |
|
-60.55% |
|
$-161.92M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
1.71 |
|
0.89 |
|
101.43 |
|
7.09% |
|
7.09% |
|
-12.47% |
|
13.91% |
|
$-5.95 |
|
$-2.21 |
|
$-2.20 |
|